Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study-Reference-Cited by-同舟云学术

Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study

Published:2013-07-30 Issue:3 Volume:98 Page:323-330
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Katsutani Shinya,Tomiyama Yoshiaki,Kimura Akiro,Miyakawa Yoshitaka,Okamoto Shinichiro,Okoshi Yasushi,Ninomiya Haruhiko,Kosugi Hiroshi,Ishii Kazuyoshi,Ikeda Yasuo,Hattori Toshihiro,Katsura Koichi,Kanakura Yuzuru

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-013-1401-1.pdf

Reference27 articles.

1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–93.

2. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.

3. Kurata Y, Fujimura K, Kuwana M, Tomiyama Y, Murata M. Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review. Int J Hematol. 2011;93:329–35.

4. Butros LJ, Bussel JB. Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol. 2003;25:660–4.

5. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000;160:1630–8.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience;Cureus;2022-06-06

2. Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul;Indian Journal of Hematology and Blood Transfusion;2021-07-05

3. Management of primary immune thrombocytopenia in a real-world setting in Japan: eltrombopag versus corticosteroids;International Journal of Hematology;2021-04-13

4. Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2021-01-01

5. A simple HPLC assay for determining eltrombopag concentration in human serum;Biomedical Chromatography;2020-12-29